Compare NOV & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NOV | TXG |
|---|---|---|
| Founded | 1862 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 8.5B |
| IPO Year | 1996 | 2019 |
| Metric | NOV | TXG |
|---|---|---|
| Price | $19.84 | $70.90 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 20 | 19 |
| Target Price | $22.13 | ★ $77.00 |
| AVG Volume (30 Days) | 3.1M | ★ 3.8M |
| Earning Date | 10-27-2026 | 11-05-2026 |
| Dividend Yield | ★ 2.40% | N/A |
| EPS Growth | N/A | ★ 76.97 |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $8,744,000,000.00 | $245,893,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.98 | $10.13 |
| P/E Ratio | $376.30 | ★ N/A |
| Revenue Growth | N/A | ★ 68.06 |
| 52 Week Low | $13.85 | $12.34 |
| 52 Week High | $21.93 | $102.81 |
| Indicator | NOV | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 55.48 | 45.30 |
| Support Level | $19.77 | $56.98 |
| Resistance Level | $20.01 | $102.81 |
| Average True Range (ATR) | 0.53 | 7.54 |
| MACD | 0.12 | -1.56 |
| Stochastic Oscillator | 95.43 | 10.29 |
NOV (formerly National Oilwell Varco) designs, manufactures, and sells a wide range of equipment and components supplying the oil and gas industry, including rig equipment, downhole tools, drill pipe, and well casing. NOV's customers include major integrated oil companies, national oil companies, independent oil and gas companies, and drilling contractors. Its operations are organized into two reportable segments: energy products and services and energy equipment. NOV operates on a global scale, with international markets contributing nearly two-thirds of its annual revenue.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).